| 视网膜静脉阻塞继发黄斑水肿的抗VEGF药物治疗进展 |
| |
| 引用本文： | 夏松,陈有信. 视网膜静脉阻塞继发黄斑水肿的抗VEGF药物治疗进展[J]. 眼科新进展, 2016, 0(11): 1093-1096. DOI: 10.13389/j.cnki.rao.2016.0292 |
| |
| 作者姓名： | 夏松 陈有信 |
| |
| 作者单位： | 100730 北京市，中国医学科学院北京协和医院 |
| |
| 摘 要： | 视网膜静脉阻塞是一种常见的眼科疾病，黄斑水肿是其重要临床表现，对视力有重要损害。血管内皮生长因子（ｖａｓｃｕｌａｒｅｎｄｏｔｈｅｌｉａｌｇｒｏｗｔｈｆａｃｔｏｒ，ＶＥＧＦ）在视网膜静脉阻塞继发黄斑水肿形成中可能具有重要作用，因此，抗ＶＥＧＦ药物的应用，提供了新的治疗手段，雷珠单抗、贝伐单抗、阿柏西普、康柏西普是临床上用于玻璃体内注射的主要抗ＶＥＧＦ药物，本文就各种抗ＶＥＧＦ药物的临床疗效作一综述。
|
| 关 键 词： | 视网膜静脉阻塞 黄斑水肿 血管内皮生长因子 抗血管内皮生长因子 |
Research progress on anti-VEGF drugs for macular edema secondary to retinal vein occlusion |
| |
| XIA Song,CHEN You-Xin. Research progress on anti-VEGF drugs for macular edema secondary to retinal vein occlusion[J]. Recent Advances in Ophthalmology, 2016, 0(11): 1093-1096. DOI: 10.13389/j.cnki.rao.2016.0292 |
| |
| Authors: | XIA Song CHEN You-Xin |
| |
| Affiliation: | Peking Union Medical College , Peking Union Hospital , Beijing 100730 , China |
| |
| Abstract: | Retinal vein occlusion( RVO) is a common disease. Macular edema is the important performance which leads to server visual loss. Vascular endothelial growth factor (VEGF) plays an important role in the development of RVO. The application of anti-VEGF drugs provides a new method for the treatment of macular edema. Ranibizumab.aflibercept, conbercept are the main types of the anti-VEGF drugs, which are used for clinical treatment. This article reviews the clinical effects of various anti-VEGF drugs. |
| |
| Keywords: | retinal vein occlusion macular edema vascular endothelial growth factor anti vascular endothelial growth factor |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《眼科新进展》浏览原始摘要信息 |
|
点击此处可从《眼科新进展》下载全文 |
